院前12导联心电图与急性冠脉综合征结局的关联
PHECG与30天死亡(调整OR 0.77,95%CI 0.75-0.80)和1年死亡(调整OR 0.69,95%CI 0.68-0.71)风险降低相关,STEMI患者再灌注率更高(调整OR 4.37,95%CI 4.20-4.54)。
要点
- ACS患者院前心电图使用率逐年上升,但研究末期仍有15%合格患者未接受。
- 接受院前心电图者30天和1年全因死亡风险显著降低。
- STEMI患者接受院前心电图者再灌注治疗率更高。
核心结论
- 院前心电图使用与ACS患者短期死亡风险降低及STEMI患者再灌注率提高相关。
主要发现
- 接受院前心电图者较未接受者更年轻(中位年龄70岁 vs 75岁),女性比例更低(32.8% vs 41.9%),糖尿病(20.8% vs 24.7%)和外周血管病(4.1% vs 4.8%)比例更低。
- 接受院前心电图者30天死亡率7.1% vs 10.9%,调整OR 0.77(95%CI 0.75-0.80);1年死亡率14.2% vs 23.2%,调整OR 0.69(95%CI 0.68-0.71)。
- STEMI患者接受院前心电图者再灌注率84.5% vs 54.7%,调整OR 4.37(95%CI 4.20-4.54)。
关键数值与推荐
- 临床指南推荐对疑似ACS的急救患者进行院前12导联心电图评估。
临床怎么用
- 急救人员应对疑似ACS患者常规记录院前12导联心电图,以改善风险分层和再灌注决策。
局限性
- 观察性设计不能排除残余混杂,调整仅涵盖人口学特征、合并症和病史。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE/BACKGROUND: The 12-lead ECG is recommended in clinical guidelines for prehospital assessment of patients with suspected acute coronary syndrome (ACS) presenting to Emergency Medical Services (EMS). OBJECTIVES: To determine prehospital ECG (PHECG) utilisation since UK national rollout of primary percutaneous coronary intervention, and whether this is associated with clinical outcomes in patients with ACS. DESIGN: Population-based, linked cohort study using Myocardial Ischaemia National Audit Project data from 1 January 2010 to 31 December 2017, related to patients with ACS conveyed by the EMS to hospital in England and Wales. EXPOSURE: PHECG administration. OUTCOMES: Proportion of patients where PHECG was recorded, 30-day and 1 year all-cause mortality, use of reperfusion. RESULTS: Of 330 713 eligible patients transferred by EMS, 263 420 patients (79.7%) had PHECG recorded, steadily increasing from 74.2% in 2010 to 85.0% in 2017. Patients who received PHECG were generally younger than those who did not (median age: 70 years vs 75 years), less likely to be female (32.8% vs 41.9%) or to have comorbidities such as diabetes (20.8% vs 24.7%) or peripheral vascular disease (4.1% vs 4.8%). Patients who received PHECG had lower mortality at 30 days (7.1% vs 10.9%), with adjusted OR 0.77 (95% CI 0.75 to 0.80), and at 1 year (14.2% vs 23.2%), with adjusted OR 0.69 (95% CI 0.68 to 0.71). Adjustment accommodated demographic characteristics, comorbidities and medical history. Reperfusion was more frequent in patients with ST-elevation myocardial infarction (STEMI) receiving PHECG (84.5% vs 54.7%) with adjusted OR 4.37 (95% CI 4.20 to 4.54), with similar adjustment. CONCLUSIONS: Use of PHECG by EMS for patients with ACS is associated with lower short-term mortality and higher odds of receiving reperfusion for STEMI patients. Administration of PHECG increased steadily over time, but at the end of the study, still 15% of eligible patients did not receive a PHECG.
引用
- Driscoll, Black, Davies, et al. Prehospital 12-lead ECG and outcomes in acute coronary syndrome. Heart. 2026. PMID: 40930592. doi:10.1136/heartjnl-2025-325780
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。